Tim Elliott

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 8

Top Venues

Cancer immunology, immunotherapy : CII

The Journal of biological chemistry

Biochemistry

Proceedings of the National Academy of Sciences of the United States of America

University of Southampton

University of Southampton (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southampton Sep 01 2000

United Kingdom

Professor of Experimental Oncology :: Medicine

Education History

University of Southampton

United Kingdom

PHD :: Medicine

Publications

Samuel Luke Hill, Gessa Sugiyarto, Jack Harrington, Edward James, Timothy J Underwood, Tim Elliott
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma. Cancer immunology, immunotherapy : CII 73 (11) (2024)
Lion F K Uhl, Han Cai, Sophia L Oram, Jagdish N Mahale, Andrew J MacLean, Julie M Mazet, Theo Piccirilli, Alexander J He, Doreen Lau, Tim Elliott, Audrey Gerard
Interferon-γ couples CD8 + T cell avidity and differentiation during infection. Nature communications 14 (1) (2023)
Paul Skipp, Alistair Bailey, Katy J McCann, Oliver Wood, Robert C Walker, Robert Parker, Nicola Ternette, Tim Elliott, Timothy J Underwood, Peter W M Johnson, Paul J Skipp
Identification of neoantigens in oesophageal adenocarcinoma. Immunology (2022)
Arman A Bashirova, Mathias Viard, Vivek Naranbhai, Alba Grifoni, Wilfredo Garcia-Beltran, Marjan Akdag, Yuko Yuki, Xiaojiang Gao, Colm O'hUigin, Malini Raghavan, Steven Wolinsky, Jay H Bream, Priya Duggal, Jeremy Martinson, Nelson L Michael, Gregory D Kirk, Susan P Buchbinder, David Haas, James J Goedert, Steven G Deeks, Jacques Fellay, Bruce D Walker, Philip Goulder, Peter Cresswell, Tim Elliott, Alessandro Sette, Jonathan Carlson, Mary N Carrington
HLA tapasin independence: broader peptide repertoire and HIV control. Proceedings of the National Academy of Sciences of the United States of America 117 (45) (2020)
Emma Reeves, Oliver Wood, Christian Hermann Ottensmeier, Emma V King, Gareth J Thomas, Tim Elliott, Edward James
HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC. Cancer immunology research 7 (7) (2019)
Bruce J MacLachlan, Garry Dolton, Athanasios Papakyriakou, Alexander Greenshields-Watson, Georgina H Mason, Andrea Schauenburg, Matthieu Besneux, Barbara Szomolay, Tim Elliott, Andrew K Sewell, Awen M Gallimore, Pierre J Rizkallah, David K Cole, Andrew Godkin
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope. The Journal of biological chemistry 294 (52) (2019)
Tim Elliott, Andy van Hateren
Protein Plasticity and Peptide Editing in the MHC I Antigen Processing Pathway. Biochemistry 57 (9) (2018)
Clemens Hermann, Andy van Hateren, Fatima Ahmetlić, Andreas Neerincx, Patrick J Duriez, Stefan Stevanovic, John Trowsdale, Janet E Deane, Tim Elliott, Louise H Boyle
TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst. eLife 4 (2015)

Tim Elliott.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tim Elliott